BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29043831)

  • 1. DEL phenotype.
    Kwon DH; Sandler SG; Flegel WA
    Immunohematology; 2017 Sep; 33(3):125-132. PubMed ID: 29043831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of the 'Asia type' DEL with weak D phenotype in chinese.
    Hou J; Li J; Xia Y; Zhang X; Yang J; Li M; Zhou Y
    Transfus Clin Biol; 2023 Nov; 30(4):387-392. PubMed ID: 37380099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-D alloimmunization by Asia type DEL red blood cell units in a D-negative Thai patient.
    Thongbut J; Bénech C; Phiri N; Suwanwootichai P; Thongpao C; Bejrachandra S; Kupatawintu P; Chaiwanichsiri D; Fichou Y
    Transfus Apher Sci; 2023 Dec; 62(6):103837. PubMed ID: 37872073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with Asian-type DEL can safely be transfused with RhD-positive blood.
    Ji Y; Luo Y; Wen J; Sun Y; Jia S; Ou C; Yang W; Chen J; Ye H; Liu X; Liang Y; Lu Z; Feng Y; Wu X; Xiao M; Mo J; Zhou Z; Wang Z; Liao Z; Chen J; Wei L; Luo G; Santoso S; Fichou Y; Flegel WA; Shao C; Li C; Zhang R; Fu Y
    Blood; 2023 Apr; 141(17):2141-2150. PubMed ID: 36638337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DEL in China: the D antigen among serologic RhD-negative individuals.
    Yin Q; Flegel WA
    J Transl Med; 2021 Oct; 19(1):439. PubMed ID: 34670559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of DEL phenotype in the Indian population: Insights from next-generation sequencing analysis of two cases.
    Rophina M; Sinha A; Biswas D; Basu D; Datta SS; Scaria V
    Transfus Apher Sci; 2024 Apr; 63(2):103872. PubMed ID: 38272782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEL variants: review of molecular mechanisms, clinical consequences and molecular testing strategy.
    Yin Q
    Funct Integr Genomics; 2023 Oct; 23(4):318. PubMed ID: 37840046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 40 years of researching the Del phenotype results in a change of transfusion practice.
    Flegel WA; Srivastava K
    Transfusion; 2024 Jun; ():. PubMed ID: 38899801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When should RhD-negative recipients be spared the transfusion of DEL red cells to avoid anti-D alloimmunization?
    Ohto H; Flegel WA; Safic Stanic H
    Transfusion; 2022 Nov; 62(11):2405-2408. PubMed ID: 36156264
    [No Abstract]   [Full Text] [Related]  

  • 10. Single Molecule Fluorescence Microscopy and Machine Learning for Rhesus D Antigen Classification.
    Borgmann DM; Mayr S; Polin H; Schaller S; Dorfer V; Obritzberger L; Endmayr T; Gabriel C; Winkler SM; Jacak J
    Sci Rep; 2016 Sep; 6():32317. PubMed ID: 27580632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic characterisation of clinically significant blood group variants in Aboriginal Australians.
    Jadhao S; Davison C; Roulis E; Lee S; Campbell T; Griffin R; Toombs M; Brown A; Perry M; Nasir B; Irving DO; Hyland CA; Flower RL; Nagaraj SH
    Blood Transfus; 2024 Mar; ():. PubMed ID: 38557323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe transfusion in Asian-type DEL.
    Hess JR
    Blood; 2023 Apr; 141(17):2044-2046. PubMed ID: 37103952
    [No Abstract]   [Full Text] [Related]  

  • 13. Two large deletions extending beyond either end of the RHD gene and their red cell phenotypes.
    Srivastava K; Stiles DA; Wagner FF; Flegel WA
    J Hum Genet; 2018 Jan; 63(1):27-35. PubMed ID: 29215093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEL.
    Flegel WA; Wagner FF
    Blood Transfus; 2020 May; 18(3):159-162. PubMed ID: 32203009
    [No Abstract]   [Full Text] [Related]  

  • 15. Two Cases of Anti-D Alloimmunization in D-Negative Thai Patients as a Result of the Asian-Type DEL on Transfused Red Cells.
    Suksard K; Luangtrakool K; Rungroung T; Chamsai S; Saetam P; Kittisares K; Permpikul P; Kittivorapart J
    Transfus Med Hemother; 2024 Apr; 51(2):122-125. PubMed ID: 38584693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A).
    Jeong IH; Yu S; Kim TY; Oh SY; Cho D
    Ann Lab Med; 2024 Jul; 44(4):307-313. PubMed ID: 38384203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asian-type DEL (RHD*DEL1) with an allo-anti-D: A paradoxical observation in a healthy multiparous woman.
    Ohto H; Ito S; Srivastava K; Ogiyama Y; Uchikawa M; Nollet KE; Flegel WA
    Transfusion; 2023 Aug; 63(8):1601-1611. PubMed ID: 37465939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologically D-negative blood donors in Thailand: molecular variants and diagnostic strategy.
    Nuchnoi P; Thongbut J; Bénech C; Kupatawintu P; Chaiwanichsiri D; Férec C; Fichou Y
    Blood Transfus; 2023 May; 21(3):209-217. PubMed ID: 36346882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceed with care: the "uncommon" serologic weak D phenotypes.
    Flegel WA
    Blood Transfus; 2021 Jul; 19(4):272-276. PubMed ID: 34704554
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.